LB Pharmaceuticals is a drug development company focused on development treatments for CNS disorders. The company's lead compound is LB-102; a novel benzamide being developed the treatment of schizophrenia owned and development internally by LB. LB-102 recently completed a Phase 1 study; a First-in-... Read more
This company has no teams yet
Bristol-Myers Squibb
282 followers
Astellas Pharma
47 followers
NYU Langone Health
35 followers
West Pharmaceutical Services
11 followers
Curia Global
8 followers
AbbVie
310 followers
Navitus Health
6 followers
Xeris Pharmaceuticals
4 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
7 followers